Hi-Clearance (1788) - Total Liabilities

Latest as of September 2025: NT$2.03 Billion TWD ≈ $63.91 Million USD

Based on the latest financial reports, Hi-Clearance (1788) has total liabilities worth NT$2.03 Billion TWD (≈ $63.91 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Hi-Clearance (1788) cash flow conversion to assess how effectively this company generates cash.

Hi-Clearance - Total Liabilities Trend (2015–2024)

This chart illustrates how Hi-Clearance's total liabilities have evolved over time, based on quarterly financial data. Check Hi-Clearance (1788) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Hi-Clearance Competitors by Total Liabilities

The table below lists competitors of Hi-Clearance ranked by their total liabilities.

Company Country Total Liabilities
Mycenax Biotech
TWO:4726
Taiwan NT$1.69 Billion
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
Brazil R$3.96 Billion
Gem Terminal Industry Co Ltd
TW:2460
Taiwan NT$2.99 Billion
AMA Group Ltd
AU:AMA
Australia AU$649.09 Million
Kardemir Karabuk Demir Celik Sanayi ve Ticaret AS Class A
IS:KRDMA
Turkey TL35.63 Billion
Newbury Street II Acquisition Corp Class A Ordinary Shares
NASDAQ:NTWO
USA $6.18 Million
Corem Property Group AB (publ)
ST:CORE-D
Sweden Skr36.64 Billion
Ubright Optronics
TWO:4933
Taiwan NT$1.03 Billion

Liability Composition Analysis (2015–2024)

This chart breaks down Hi-Clearance's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 1788 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.70 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.69 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.41 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hi-Clearance's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hi-Clearance (2015–2024)

The table below shows the annual total liabilities of Hi-Clearance from 2015 to 2024.

Year Total Liabilities Change
2024-12-31 NT$1.96 Billion
≈ $61.70 Million
+19.86%
2023-12-31 NT$1.63 Billion
≈ $51.48 Million
-21.03%
2022-12-31 NT$2.07 Billion
≈ $65.19 Million
-3.02%
2021-12-31 NT$2.13 Billion
≈ $67.22 Million
-2.57%
2020-12-31 NT$2.19 Billion
≈ $68.99 Million
+12.73%
2019-12-31 NT$1.94 Billion
≈ $61.20 Million
+46.25%
2018-12-31 NT$1.33 Billion
≈ $41.85 Million
+34.40%
2017-12-31 NT$988.28 Million
≈ $31.14 Million
+8.25%
2016-12-31 NT$912.94 Million
≈ $28.76 Million
+0.86%
2015-12-31 NT$905.20 Million
≈ $28.52 Million
--

About Hi-Clearance

TWO:1788 Taiwan Medical Devices
Market Cap
$190.76 Million
NT$6.05 Billion TWD
Market Cap Rank
#16723 Global
#817 in Taiwan
Share Price
NT$136.00
Change (1 day)
+0.37%
52-Week Range
NT$135.50 - NT$144.50
All Time High
NT$149.30
About

Hi-Clearance Inc. supplies medical devices for the renal, cardiac, radiation, dental, oral surgery, and metabolism markets in Taiwan. The company offers dialyzers, dialysis and RO machines, and related consumables and drugs; interventional cardiology and radiology, and vascular surgery devices; dental consumables, implant materials, and equipment; and blood glucose monitors, and related consumabl… Read more